STOK Key Financial Ratios - Stoke Therapeutics, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	7.69	—	-52.77%	-60.17%
2026-03-31	8.99	—	-38.30%	-42.99%
2025-12-31	5.28	—	-1.65%	-1.95%
2025-09-30	6.53	—	11.26%	13.17%
2025-06-30	6.98	—	13.65%	15.67%
2025-03-31	8.41	—	12.36%	14.36%
2024-12-31	5.81	—	-32.77%	-38.85%
2024-09-30	5.09	—	-35.95%	-45.43%
2024-06-30	6.67	—	-33.65%	-42.67%
2024-03-31	5.43	—	-52.89%	-77.33%
2023-12-31	6.99	—	-45.85%	-65.62%
2023-09-30	9.13	—	-43.10%	-59.77%
2023-06-30	11.28	—	-40.86%	-55.19%
2023-03-31	8.57	—	-35.12%	-46.28%
2022-12-31	7.77	—	-39.47%	-54.68%
2022-09-30	9.19	—	-35.97%	-48.92%
2022-06-30	10.46	—	-31.96%	-42.95%
2022-03-31	13.35	—	-29.65%	-39.03%
2021-12-31	13.37	—	-35.92%	-39.40%
2021-09-30	20.61	—	-29.92%	-31.96%
2021-06-30	31.75	—	-25.34%	-26.27%
2021-03-31	45.06	—	-20.79%	-21.29%
2020-12-31	25.73	—	-17.54%	-18.26%
2020-09-30	29.02	—	-23.93%	-24.85%
2020-06-30	35.41	—	-20.34%	-21.02%
2020-03-31	39.56	—	-17.04%	-17.55%
2019-12-31	55.12	—	-14.13%	-14.40%
2019-09-30	48.14	—	-11.07%	-11.32%
2019-06-30	50.74	—	-8.59%	-8.76%
2019-03-31	—	—	—	-16.42%
2018-12-31	43.03	—	-11.64%	-11.92%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	5.28	—	-1.65%	-1.95%
2024-12-31	5.81	—	-32.77%	-38.85%
2023-12-31	6.99	—	-45.85%	-65.62%
2022-12-31	7.77	—	-39.47%	-54.68%
2021-12-31	13.37	—	-35.92%	-39.40%
2020-12-31	25.73	—	-17.54%	-18.26%
2019-12-31	55.12	—	-14.13%	-14.40%
2018-12-31	43.03	—	-11.64%	-11.92%